685565-16-6 Usage
Organic Compound
It is a carbon-based compound, with carbon atoms forming the backbone of its structure.
Isoindole Family
It belongs to a group of chemical compounds that share a common isoindole structure.
Fluorine Atom
The compound contains one fluorine atom, which can influence its reactivity and properties.
Phenylmethyl Group
The presence of a phenylmethyl group (a benzene ring attached to a methyl group) in its structure can affect its chemical properties and potential applications.
Pharmaceutical Intermediate
The compound has potential applications as a pharmaceutical intermediate, which can be used to synthesize other pharmaceutical compounds.
Biological Activities
BMS-794833 may have biological activities that could make it useful in drug development, although further research is needed to determine its specific effects.
Relatively New Compound
As a relatively new compound, BMS-794833 may have undiscovered properties and potential uses that could be revealed through additional research.
Check Digit Verification of cas no
The CAS Registry Mumber 685565-16-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,5,5,6 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 685565-16:
(8*6)+(7*8)+(6*5)+(5*5)+(4*6)+(3*5)+(2*1)+(1*6)=206
206 % 10 = 6
So 685565-16-6 is a valid CAS Registry Number.
685565-16-6Relevant articles and documents
RHO KINASE INHIBITORS
-
, (2015/04/28)
The invention provides novel inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or ROCK2. The present invention includes pharmaceutical compositions comprising the compounds of the invention and a pharmaceutically acceptable carrier and/or diluents. The present invention includes compositions comprising a substantially pure compound of the invention and a pharmaceutically acceptable salt, steroisomer, or hydrate thereof: and a pharmaceutically acceptable excipient and/or diluents.
BICYCLIC BENZAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGAND USEFUL IN THE TREATMENT OF NEUROLOGICAL DISEASES
-
Page 14, (2008/06/13)
The present invention relates to novel bicyclic benzamide derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
